In-vitro activity of cefoperazone-sulbactam against Bacteroides species
- PMID: 3021709
- DOI: 10.1093/jac/18.4.467
In-vitro activity of cefoperazone-sulbactam against Bacteroides species
Abstract
The in-vitro activity of two combinations of sulbactam and cefoperazone against 187 strains of Bacteroides fragilis were evaluated; their activity was compared with that of the drugs alone, and correlated with the production of beta-lactamase by the bacterial strains. The results indicated that both combinations had a synergistic effect: the addition of 8 mg/l of sulbactam to the MIC of cefoperazone reduced the percentage of resistant strains from 58% to 0.5%; while the combination of two parts of cefoperazone to one pact of sulbactam lowered the resistance rate to 1%. Synergy was observed most frequently with beta-lactamase positive strains, but it also occurred among beta-lactamase negative strains.
Similar articles
-
Activity of cefoperazone and two beta-lactamase inhibitors, sulbactam and clavulanic acid, against Bacteroides spp. correlated with beta-lactamase production.Antimicrob Agents Chemother. 1982 Sep;22(3):398-405. doi: 10.1128/AAC.22.3.398. Antimicrob Agents Chemother. 1982. PMID: 6291451 Free PMC article.
-
The cefoperazone-sulbactam combination. In vitro qualities including beta-lactamase stability, antimicrobial activity, and interpretive criteria for disk diffusion tests.Am J Clin Pathol. 1985 Oct;84(4):496-504. doi: 10.1093/ajcp/84.4.496. Am J Clin Pathol. 1985. PMID: 2994461
-
In vitro activity of cefoperazone/sulbactam and other antimicrobials against anaerobic bacteria.Diagn Microbiol Infect Dis. 1990 Jan-Feb;13(1):51-5. doi: 10.1016/0732-8893(90)90054-y. Diagn Microbiol Infect Dis. 1990. PMID: 2331850
-
beta-Lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone.Clin Infect Dis. 1997 Mar;24(3):494-7. doi: 10.1093/clinids/24.3.494. Clin Infect Dis. 1997. PMID: 9114205 Review.
-
Cefoperazone/sulbactam: New composites against multiresistant gram negative bacteria?Infect Genet Evol. 2021 Mar;88:104707. doi: 10.1016/j.meegid.2021.104707. Epub 2021 Jan 5. Infect Genet Evol. 2021. PMID: 33418147 Review.
Cited by
-
Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents.Antimicrob Agents Chemother. 1991 Jun;35(6):1214-8. doi: 10.1128/AAC.35.6.1214. Antimicrob Agents Chemother. 1991. PMID: 1929264 Free PMC article.
-
In vitro activity of cefoperazone plus sulbactam compared with that of other antimicrobial agents against anaerobic bacteria.Antimicrob Agents Chemother. 1988 Mar;32(3):403-6. doi: 10.1128/AAC.32.3.403. Antimicrob Agents Chemother. 1988. PMID: 3364960 Free PMC article.
-
Beta-lactamase inhibitors from laboratory to clinic.Clin Microbiol Rev. 1988 Jan;1(1):109-23. doi: 10.1128/CMR.1.1.109. Clin Microbiol Rev. 1988. PMID: 3060240 Free PMC article. Review.
-
Beta-lactam/beta-lactamase inhibitor combinations: development, antibacterial activity and clinical applications.Infection. 1995 Jul-Aug;23(4):191-200. doi: 10.1007/BF01781195. Infection. 1995. PMID: 8522374 Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous